GL1X · GenesisL1 explorer

Research workbench

Thrombin in complex with an oxazolopyridine inhibitor 2

Analyse Thrombin in complex with an oxazolopyridine inhibitor 2 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1ZGV
Type
protein
Length
286 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thrombin; Hirudin
EC
3.4.21.5
UniProt
P00734, P28511
Ligands
501
Pockets
2 · best druggability 0.54

Structure

x-ray diffraction · 2 distinct chains · 16% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AThrombin (EC 3.4.21.5)protein27617% helix, 32% strandP00734
BHirudinprotein100% helix, 0% strandP28511

Ligands and binding sites

  • 501 · N7-butyl-N2-(5-chloro-2-methylphenyl)-5-methyl[1,2,4]triazolo[1,5-a]pyrimidine-2,7-diamine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12580.540.7638501
2500.310.7718empty

Interfaces

1 interface between chains.

  • A–B · 670 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 1 modified (disulfide, sulfation).

Compared structures

  • 1ZGV · Thrombin in complex with an oxazolopyridine inhibitor 2 · the same entry in another collection · chain B against B, TM-score 1.00
  • P28511 · AlphaFold monomer V2.0 prediction for hirudin-3B' (P28511) · a predicted model of the same protein · chain B against A, TM-score 0.57

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.